Zoetis Inc. (NYSE:ZTS) Stake Boosted by Aberdeen Wealth Management LLC

Aberdeen Wealth Management LLC raised its position in shares of Zoetis Inc. (NYSE:ZTS) by 1.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,566 shares of the company’s stock after buying an additional 68 shares during the quarter. Aberdeen Wealth Management LLC’s holdings in Zoetis were worth $697,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Zoetis in the third quarter valued at $49,325,000. Banque Cantonale Vaudoise increased its holdings in shares of Zoetis by 2.2% in the 3rd quarter. Banque Cantonale Vaudoise now owns 82,320 shares of the company’s stock valued at $16,084,000 after purchasing an additional 1,753 shares during the period. Princeton Capital Management LLC lifted its position in shares of Zoetis by 1.2% in the third quarter. Princeton Capital Management LLC now owns 11,488 shares of the company’s stock worth $2,244,000 after purchasing an additional 133 shares in the last quarter. Caprock Group LLC grew its position in Zoetis by 7.3% during the third quarter. Caprock Group LLC now owns 11,984 shares of the company’s stock valued at $2,342,000 after purchasing an additional 811 shares in the last quarter. Finally, Pathstone Holdings LLC grew its position in Zoetis by 0.5% during the third quarter. Pathstone Holdings LLC now owns 60,660 shares of the company’s stock valued at $11,852,000 after purchasing an additional 310 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ZTS has been the subject of a number of research reports. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. lifted their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Piper Sandler upped their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. BTIG Research lifted their price target on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Finally, Stifel Nicolaus increased their price objective on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $221.44.

Zoetis Stock Up 0.7 %

Shares of Zoetis stock opened at $176.42 on Tuesday. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The stock has a 50 day moving average price of $186.78 and a two-hundred day moving average price of $180.45. The stock has a market capitalization of $79.60 billion, a P/E ratio of 33.16, a PEG ratio of 2.69 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. Zoetis’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.36 EPS. Equities analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.